resveratrol has been researched along with Ventricular Dysfunction, Left in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dolinsky, VW; Dyck, JR; Haykowsky, MJ; Jones, LW; Rogan, KJ; Sung, MM; Young, ME; Zordoky, BN | 1 |
| Dellsperger, KC; Ma, L; Morgan, B; Potter, BJ; Ungvari, Z; Zhang, C; Zhang, H | 1 |
| Chen, G; Feng, Y; Liu, M; Luo, Q; Qu, S; Wei, X; Xiao, X; Zhang, C; Zhu, H | 1 |
| Das, DK; Juric, D; Netticadan, T; Wojciechowski, P | 1 |
| Aubin, MC; Calderone, A; Clément, R; Gosselin, H; Lajoie, C; Perrault, LP | 1 |
5 other study(ies) available for resveratrol and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Biomarkers; Blood Pressure; Blotting, Western; Dietary Supplements; Doxorubicin; Electron Transport Chain Complex Proteins; Female; GTP Phosphohydrolases; Heart Diseases; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Mitochondria, Heart; Physical Conditioning, Animal; Resveratrol; Stilbenes; Ventricular Dysfunction, Left | 2013 |
Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging.
Topics: Animals; Antioxidants; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; NADPH Oxidase 2; NADPH Oxidases; NF-kappa B; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Oxygen; Reactive Oxygen Species; Resveratrol; Stilbenes; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left | 2010 |
Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53.
Topics: Acetylation; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Body Weight; Cytochromes c; Doxorubicin; Gene Expression; Male; Mice; Mice, Inbred BALB C; Myocardium; Myocytes, Cardiac; Organ Size; Oxidative Stress; Resveratrol; Sirtuin 1; Stilbenes; Tumor Suppressor Protein p53; Ventricular Dysfunction, Left | 2011 |
Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol.
Topics: Animals; Aorta; Dose-Response Relationship, Drug; Hypertension; Hypertrophy, Left Ventricular; Male; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Stilbenes; Stroke Volume; Treatment Outcome; Ultrasonography; Vasodilator Agents; Ventricular Dysfunction, Left | 2007 |
Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: therapeutic potential of resveratrol.
Topics: Acetylcholine; Animals; Antioxidants; Aorta; Blood Pressure; Dietary Fats; Female; Fibrosis; Hyperlipidemias; Myocardium; Nitroprusside; Obesity; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Vasodilation; Vasodilator Agents; Ventricular Dysfunction, Left | 2008 |